Discussion on clinical trials of the fenamates.
D000698:Analgesia; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D002490:Central Nervous System / Q000502:physiology; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006396:Hematemesis / Q000139:chemically induced; D006801:Humans; D008528:Mefenamic Acid / Q000009:adverse effects; D008551:Melena / Q000139:chemically induced; D010653:Phenylbutazone / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage; D011485:Protein Binding / Q000187:drug effects; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D005461:Fluorine; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D010653:Phenylbutazone; D001241:Aspirin; D011241:Prednisone